• 1
    Melo JV, Hughes TP, Apperley JF. Chronic myeloid leukemia. American Society of Hematology Education Program Book2003; 132152.
  • 2
    Smith DF, Whitesell L, Katsanis E. Molecular chaperones: biology and prospects for pharmacological intervention. Pharmacol Rev 1998; 50: 493513.
  • 3
    Sattler M, Verma S, Shrikhande G, Byrne CH, Pride YB, Winkler T, Greenfield EA, Salgia R, Griffin JD, Christopher HB, Yuri BP. The BCR-ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells. The J Biol Chem 2000; 275: 242738.
  • 4
    Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, Goldschmidt-Clermont PJ. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 1997; 275: 164952.
  • 5
    Albini A, Morini M, Agostini FD. Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-Acetylcysteine. Cancer Res 2001; 15: 81718.
  • 6
    Mayerhofer M, Valent P, Sperr WR, Griffin JD, Sillaber C. BCR-ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1a, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin. 2002; 100: 376775.
  • 7
    Kin Y, Li G, Shibuya M, Maru Y. The Dbl-homology domain of BCR is not a simple spacer in P210BCR-ABL of the Philadelphia chromosome. J Biol Chem 2001; 276: 394628.
  • 8
    Maru Y, Yamaguchi S, Shibuya M. FLT1, a receptor for vascular endothelial growth factor, has transforming and morphogenic potentials. Oncogene 1998; 16: 258595.
  • 9
    Maru Y, Yamaguchi S, Takahashi T, Ueno H, Shibuya M. Virally Activated Ras Cooperates With Integrin to Induce Tubulogenesis in Sinusoidal Endothelial Cell Lines. J Cell Physiol 1998; 176: 22334.
  • 10
    Maru YK, Hanks SK, Shibuya M. The tubulogenic activity associated with an activated form of Flt-1 kinase is dependent on focal adhesion kinase. Mol Cell Res, Biochim et Biophy Acta 2001; 1540: 14753.
  • 11
    Gaenshirt H, Morianz K. Reseearch on the quantitative evaluation of thin layer chromatography. I. UV-spectroscopic determination of mixtures of the methyl and propyl esters of p-hydroxybenzoic acid after separation by thin layer chromatography. Arch Pharmazie 1960; 293: 106575.
  • 12
    Jinno S, Yageta M, Nagata A, Okayama H. Cdc6 requires anchorage for its expression. Oncogene 2002; 21: 177784.
  • 13
    Palsson EM, Popoff M, Thelestam M, O'Neill LAJ. Divergent Roles for Ras and Rap in the Activation of p38 Mitogen-activated Protein Kinase by Interleukin-1. J Biol Chem 2000; 275: 781825.
  • 14
    Pamela AH, Sandra O’, RJ, Justin M, Douglas EB. Transformed and tumor-derived human cells exhibit preferential sensitivity to the thiol antioxidants, N-Acetyl Cysteine and penicillamine. Cancer Res 2002; 62: 14439.
  • 15
    Schlaepfer DD, Jones. KC, Hunter T. Multiple Grb2-Mediated Integrin-Stimulated Signaling Pathways to ERK2/Mitogen-Activated Protein Kinase. Summation of Both c-Src- and Focal Adheison Kinase-Initiated Tyrosine Phosphorylation Events. Mol Cell Biol 1998; 18: 257185.
  • 16
    Cheng K, Kurzrock R, Qiu X, Estrov Z, Ku S, Dulski KM, Wang JY, Talpaz M. Reduced focal adhesion kinase and paxillin phosphorylation in BCR-ABL-transfected cells. Cancer 2002; 95: 44050.
  • 17
    Martin KR, Kari FW, Barrett JC, French JE. N-acetyl-L-cysteine simultaneously increases mitogenesis and suppresses apoptosis in mitogen-stimulated B-lymphocytes from p53 haploinsufficient Tg.AC (v-Ha-ras) mice. In Vitr Mol Toxicol 2000; 13: 23748.
  • 18
    Deneke SM. Thiol-based antioxidants. Curr Top Cell Regul 2000; 36: 15180.
  • 19
    Banerji U, Judson I, Workman P. The clinical applicationsof heat shock protein inhibitors in cancer – present and future. Curr Cancer Drug Targets 2003; 3: 38590.